ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks

References

• Stinissen P, Hellings N. Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy? Eur J Immunol. 2008;38(5):1190–3.10.1002/(ISSN)1521-4141
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17.10.1016/S0140-6736(08)61620-7
   PubMed Web of Science ®Google Scholar
• Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146–60.10.1093/brain/awp033
   PubMed Web of Science ®Google Scholar
• Cadden MH, Koven NS, Ross KM. Neuroprotective effects of vitamin D in multiple sclerosis. Neurosci Med. 2011;2:198–207.
   Google Scholar
• Fernandes de Abreu DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34(Suppl. 1):S265–77.
   PubMedGoogle Scholar
• Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62(1):60–5.10.1212/01.WNL.0000101723.79681.38
   PubMed Web of Science ®Google Scholar
• Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and RISK of multiple sclerosis. JAMA. 2006;296(23):2832–8.10.1001/jama.296.23.2832
   PubMed Web of Science ®Google Scholar
• Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005;23(4):309–13.10.1007/s00774-005-0604-9
   PubMed Web of Science ®Google Scholar
• Runia TF1, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012;79(3):261–6.10.1212/WNL.0b013e31825fdec7
   PubMed Web of Science ®Google Scholar
• Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008;14(9):1220–4.10.1177/1352458508094399
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6S.
   PubMed Web of Science ®Google Scholar
• Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542–8.10.1210/en.2006-0946
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, et al. Structural organization of the human vitamin D receptor chromosomal gene and ist promoter. Mol Endocrinol. 1997;11(8):1165–79.10.1210/mend.11.8.9951
   PubMed Web of Science ®Google Scholar
• Simon KC, Munger KL, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler. 2010;16(2):133.10.1177/1352458509355069
   PubMed Web of Science ®Google Scholar
• Sundqvist E, Bäärnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I. Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet. 2010;18(12):1349–52.10.1038/ejhg.2010.113
   PubMed Web of Science ®Google Scholar
• Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, Csurhes P, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an australian population. J Neurogenet. 2005;19(1):25–38.10.1080/01677060590949692
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.10.1016/j.gene.2004.05.014
   PubMed Web of Science ®Google Scholar
• Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci. 2011;305(1–2):116–20.10.1016/j.jns.2011.02.032
   PubMed Web of Science ®Google Scholar
• Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999;166(1):47–52.10.1016/S0022-510X(99)00112-4
   PubMed Web of Science ®Google Scholar
• Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci. 2000;177(1):65–71.10.1016/S0022-510X(00)00336-1
   PubMed Web of Science ®Google Scholar
• Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, Zanzottera M, et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun. 2011;25(7):1460–7.10.1016/j.bbi.2011.05.015
   PubMed Web of Science ®Google Scholar
• Steckley JL1, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian collaborative study group. Neurology. 2000;54(3):729–32.10.1212/WNL.54.3.729
   PubMed Web of Science ®Google Scholar
• Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R. Association study on two vitamin d receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann NY Acad Sci. 2009;1173:515–20.10.1111/j.1749-6632.2009.04656.x
   PubMed Web of Science ®Google Scholar
• Niksresht A, Dadkhah B, Sarvestani EK. The association of vitamin D receptor gene BsmI polymorphism with multiple sclerosis in Iranian patients. J Kerman Univ Med Sci Health Serv. 2009;16(2):116–23.
   Google Scholar
• Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, Prada A, et al. HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler. 2012;18(5):569–77.
   PubMed Web of Science ®Google Scholar
• García-Martín E, Agu′ndez JAG, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, et al. Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One. 2013;8(6):e65487.
   PubMed Web of Science ®Google Scholar
• Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, et al. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed. 2011;10:3.10.1186/1477-5751-10-3
   PubMedGoogle Scholar
• Polman CH, Reingold SC, Edan G, Filippi, M, Hartung HP Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–6.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold, SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.10.1002/ana.22366
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al. Using disability and disease duration to rate disease severity. Multiple Sclerosis Severity Score. Neurology. 2005;64(7):1144–51.
   Google Scholar
• Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008;4(8):404–12.10.1038/ncprheum0855
   PubMedGoogle Scholar
• Agnello L, Scazzone C, Ragonese P, Salemi G, Lo Sasso B, Schillaci R, et al. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients. Neurol Sci. 2016;37(2):261–7.10.1007/s10072-015-2401-0
   PubMed Web of Science ®Google Scholar
• Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler. 2012;18(1):16–22.10.1177/1352458511415562
   PubMed Web of Science ®Google Scholar
• Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367(6460):284–7.10.1038/367284a0
   PubMed Web of Science ®Google Scholar